4//SEC Filing
Williams Rosemary Y. 4
Accession 0001358403-19-000008
CIK 0001358403other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:03 PM ET
Size
13.7 KB
Accession
0001358403-19-000008
Insider Transaction Report
Form 4
Williams Rosemary Y.
Principal Accounting Officer
Transactions
- Tax Payment
Common Stock
2019-01-02$3.33/sh−483$1,608→ 3,984 total - Exercise/Conversion
Restricted Stock Units
2019-01-02−1,281→ 3,844 total→ Common Stock (1,281 underlying) - Exercise/Conversion
Common Stock
2019-01-02+1,281→ 4,467 total - Exercise/Conversion
Common Stock
2019-01-03+782→ 4,766 total - Tax Payment
Common Stock
2019-01-03$3.20/sh−295$944→ 4,471 total - Exercise/Conversion
Restricted Stock Units
2019-01-03−782→ 1,562 total→ Common Stock (782 underlying)
Footnotes (5)
- [F1]Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer common stock.
- [F2]Represents the number of shares withheld by and surrendered to the Issuer on January 2, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 2, 2018 for 5,125 shares.
- [F3]Represents the number of shares withheld by and surrendered to the Issuer on January 3, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 3, 2017 for 3,125 shares.
- [F4]The RSUs vest in four equal annual installments beginning on January 2, 2019.
- [F5]The RSUs vest in four equal annual installments beginning on January 3, 2018.
Documents
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeother
Related Parties
1- filerCIK 0001747727
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:03 PM ET
- Size
- 13.7 KB